2021-02-22

The Journal of Dermatology　～多汗症新規外用薬の論文～

カテゴリー：

Yokozeki H,Fujimoto T, et.al.
A Phase 3, multi-center, randomized, double-blind, vehicle-controlled, parallel-group study of 5% sofpironium bromide (BBI-4000) gel in Japanese patients with primary axillary hyperhidrosis
http://dx.doi.org/10.1111/1346-8138.15668

«